Progenics Pharmaceuticals, Inc.
8 clinical trials · Sponsor
◉ Watch Progenics Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). (NCT03939689) | Progenics Pharmaceuticals, Inc. | 2019-05-30 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (NCT03739684) | Progenics Pharmaceuticals, Inc. | 2018-11-27 |
Track Progenics Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.